| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
|
Gotlib, Jason
|
|
|
106 |
8 |
p. 2865-2870
|
artikel
|
| 2 |
Aggregometry detects platelet hyperreactivity in healthy individuals
|
Yee, Donald L.
|
|
|
106 |
8 |
p. 2723-2729
|
artikel
|
| 3 |
An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes
|
Renaudineau, Yves
|
|
|
106 |
8 |
p. 2781-2789
|
artikel
|
| 4 |
Anti-CD40: Janus or gatekeeper?
|
Illidge, Tim
|
|
|
106 |
8 |
p. 2595-2596
|
artikel
|
| 5 |
Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation
|
Statkute, Laisvyde
|
|
|
106 |
8 |
p. 2700-2709
|
artikel
|
| 6 |
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma
|
Nademanee, Auayporn
|
|
|
106 |
8 |
p. 2896-2902
|
artikel
|
| 7 |
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron
|
Porto, Graça
|
|
|
106 |
8 |
p. 2922-2923
|
artikel
|
| 8 |
A thrombomodulin mutation that impairs activated protein C generation results in uncontrolled lung inflammation during murine tuberculosis
|
Weijer, Sebastiaan
|
|
|
106 |
8 |
p. 2761-2768
|
artikel
|
| 9 |
Botrocetin/VWF-induced signaling through GPIb-IX-V produces TxA2 in an αIIbβ3- and aggregation-independent manner
|
Liu, Junling
|
|
|
106 |
8 |
p. 2750-2756
|
artikel
|
| 10 |
CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood
|
Elshal, Mohamed F.
|
|
|
106 |
8 |
p. 2923-2924
|
artikel
|
| 11 |
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia
|
Suzuki, Tatsuya
|
|
|
106 |
8 |
p. 2854-2861
|
artikel
|
| 12 |
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy
|
Gertz, Morie A.
|
|
|
106 |
8 |
p. 2837-2840
|
artikel
|
| 13 |
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
|
Lin, Lan
|
|
|
106 |
8 |
p. 2884-2889
|
artikel
|
| 14 |
CXCL13 is an arrest chemokine for B cells in high endothelial venules
|
Kanemitsu, Naotoshi
|
|
|
106 |
8 |
p. 2613-2618
|
artikel
|
| 15 |
Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice
|
Gunshin, Hiromi
|
|
|
106 |
8 |
p. 2879-2883
|
artikel
|
| 16 |
Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes
|
Matsuda, Akira
|
|
|
106 |
8 |
p. 2633-2640
|
artikel
|
| 17 |
Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40
|
de Goër de Herve, Marie-Ghislaine
|
|
|
106 |
8 |
p. 2806-2814
|
artikel
|
| 18 |
Directing thrombin
|
Lane, David A.
|
|
|
106 |
8 |
p. 2605-2612
|
artikel
|
| 19 |
Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells
|
Delaney, Colleen
|
|
|
106 |
8 |
p. 2693-2699
|
artikel
|
| 20 |
Editorial Board
|
|
|
|
106 |
8 |
p. i
|
artikel
|
| 21 |
Extraembryonic expression of EPCR is essential for embryonic viability
|
Li, Weihong
|
|
|
106 |
8 |
p. 2716-2722
|
artikel
|
| 22 |
Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells
|
Landry, Josette-Renée
|
|
|
106 |
8 |
p. 2680-2687
|
artikel
|
| 23 |
Functional avidity directs T-cell fate in autoreactive CD4+ T cells
|
Mallone, Roberto
|
|
|
106 |
8 |
p. 2798-2805
|
artikel
|
| 24 |
Gefitinib adopts orphan kinases in leukemia
|
Pardanani, Animesh
|
|
|
106 |
8 |
p. 2600-2601
|
artikel
|
| 25 |
Gefitinib induces myeloid differentiation of acute myeloid leukemia
|
Stegmaier, Kimberly
|
|
|
106 |
8 |
p. 2841-2848
|
artikel
|
| 26 |
Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
|
Schreurs, Marco W.J.
|
|
|
106 |
8 |
p. 2663-2670
|
artikel
|
| 27 |
HCT outcomes: a new tool?
|
Jones, Roy B.
|
|
|
106 |
8 |
p. 2602-2603
|
artikel
|
| 28 |
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
|
Sorror, Mohamed L.
|
|
|
106 |
8 |
p. 2912-2919
|
artikel
|
| 29 |
HIT as a preventable disease?
|
Warkentin, Theodore E.
|
|
|
106 |
8 |
p. 2600
|
artikel
|
| 30 |
Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells
|
Caselli, Elisabetta
|
|
|
106 |
8 |
p. 2790-2797
|
artikel
|
| 31 |
Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease
|
Nishimoto, Norihiro
|
|
|
106 |
8 |
p. 2627-2632
|
artikel
|
| 32 |
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
|
Schwartz, Stefan
|
|
|
106 |
8 |
p. 2641-2645
|
artikel
|
| 33 |
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets
|
Williams, P. Claire
|
|
|
106 |
8 |
p. 2737-2743
|
artikel
|
| 34 |
In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors
|
Liu, Bianling
|
|
|
106 |
8 |
p. 2655-2662
|
artikel
|
| 35 |
It's the trophoblast!
|
Weiler, Hartmut
|
|
|
106 |
8 |
p. 2603
|
artikel
|
| 36 |
Let's not get too JAKed up!
|
Hoffman, Ronald
|
|
|
106 |
8 |
p. 2599
|
artikel
|
| 37 |
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different
|
Rimoldi, Monica
|
|
|
106 |
8 |
p. 2818-2826
|
artikel
|
| 38 |
Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome
|
Lutskiy, Maxim I.
|
|
|
106 |
8 |
p. 2815-2817
|
artikel
|
| 39 |
Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN
|
Gao, Ping
|
|
|
106 |
8 |
p. 2619-2626
|
artikel
|
| 40 |
Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell–receptor restriction in large granular lymphocyte leukemia
|
Wlodarski, Marcin W.
|
|
|
106 |
8 |
p. 2769-2780
|
artikel
|
| 41 |
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety
|
Lefrère, Jean-Jacques
|
|
|
106 |
8 |
p. 2890-2895
|
artikel
|
| 42 |
Platelet NAD(P)H-oxidase–generated ROS production regulates αIIbβ3-integrin activation independent of the NO/cGMP pathway
|
Begonja, Antonija Jurak
|
|
|
106 |
8 |
p. 2757-2760
|
artikel
|
| 43 |
Quiescent and activated mouse granulocytes do not express granzyme A and B or perforin: similarities or differences with human polymorphonuclear leukocytes?
|
Martin, Praxedis
|
|
|
106 |
8 |
p. 2871-2878
|
artikel
|
| 44 |
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease
|
Zorn, Emmanuel
|
|
|
106 |
8 |
p. 2903-2911
|
artikel
|
| 45 |
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia
|
Greinacher, Andreas
|
|
|
106 |
8 |
p. 2921-2922
|
artikel
|
| 46 |
Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET)
|
Barosi, Giovanni
|
|
|
106 |
8 |
p. 2849-2853
|
artikel
|
| 47 |
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
|
Martel, Nadine
|
|
|
106 |
8 |
p. 2710-2715
|
artikel
|
| 48 |
Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains
|
Siebenlist, Kevin R.
|
|
|
106 |
8 |
p. 2730-2736
|
artikel
|
| 49 |
The ABCCs of myelofibrosis
|
Silver, Richard T.
|
|
|
106 |
8 |
p. 2598-2599
|
artikel
|
| 50 |
The influence of N-linked glycosylation on the function of platelet glycoprotein VI
|
Kunicki, Thomas J.
|
|
|
106 |
8 |
p. 2744-2749
|
artikel
|
| 51 |
The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients
|
Goerttler, Philipp S.
|
|
|
106 |
8 |
p. 2862-2864
|
artikel
|
| 52 |
The kinetics of clonal dominance in myeloproliferative disorders
|
Catlin, Sandra N.
|
|
|
106 |
8 |
p. 2688-2692
|
artikel
|
| 53 |
Therapeutic expression of the platelet-specific integrin, αIIbβ3, in a murine model for Glanzmann thrombasthenia
|
Fang, Juan
|
|
|
106 |
8 |
p. 2671-2679
|
artikel
|
| 54 |
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis
|
van der Holt, Bronno
|
|
|
106 |
8 |
p. 2646-2654
|
artikel
|
| 55 |
The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders
|
Scott, Linda M.
|
|
|
106 |
8 |
p. 2920-2921
|
artikel
|
| 56 |
Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia
|
Gery, Sigal
|
|
|
106 |
8 |
p. 2827-2836
|
artikel
|
| 57 |
Transplantation for SLE?
|
Pavletic, Steven Z.
|
|
|
106 |
8 |
p. 2597
|
artikel
|
| 58 |
Viral rescue of murine Glanzmann thrombasthenia
|
Ware, Jerry
|
|
|
106 |
8 |
p. 2596
|
artikel
|
| 59 |
Will radioimmunotherapy replace TBI?
|
Winter, Jane N.
|
|
|
106 |
8 |
p. 2601-2602
|
artikel
|
Tijdschrift beschrijving